BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21641240)

  • 1. Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.
    Boosalis MS; Castaneda SA; Trudel M; Mabaera R; White GL; Lowrey CH; Emery DW; Mpollo MS; Shen L; Wargin WA; Bohacek R; Faller DV; Perrine SP
    Blood Cells Mol Dis; 2011 Aug; 47(2):107-16. PubMed ID: 21641240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice.
    Boosalis MS; Sangerman JI; White GL; Wolf RF; Shen L; Dai Y; White E; Makala LH; Li B; Pace BS; Nouraie M; Faller DV; Perrine SP
    PLoS One; 2015; 10(12):e0144660. PubMed ID: 26713848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cilostazol-mediated reversion of γ-globin silencing is associated with a high level of HbF production: A potential therapeutic candidate for β-globin disorders.
    Ali H; Khan F; Musharraf SG
    Biomed Pharmacother; 2021 Oct; 142():112058. PubMed ID: 34426256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
    Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
    Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease.
    Pace BS; Perrine S; Li B; Makala L; Xu H; Takezaki M; Wolf RF; Wang A; Xu X; Huang J; Alimardanov A; Tawa GJ; Sangerman J; Faller A; Zheng W; Toney L; Haugabook SJ
    Blood Cells Mol Dis; 2021 Jul; 89():102561. PubMed ID: 33744514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A cell-based high-throughput screen for novel chemical inducers of fetal hemoglobin for treatment of hemoglobinopathies.
    Peterson KR; Costa FC; Fedosyuk H; Neades RY; Chazelle AM; Zelenchuk L; Fonteles AH; Dalal P; Roy A; Chaguturu R; Li B; Pace BS
    PLoS One; 2014; 9(9):e107006. PubMed ID: 25225870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trienone analogs of curcuminoids induce fetal hemoglobin synthesis via demethylation at
    Nuamsee K; Chuprajob T; Pabuprapap W; Jintaridth P; Munkongdee T; Phannasil P; Vadolas J; Chaichompoo P; Suksamrarn A; Svasti S
    Sci Rep; 2021 Apr; 11(1):8552. PubMed ID: 33879818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
    Krivega I; Byrnes C; de Vasconcellos JF; Lee YT; Kaushal M; Dean A; Miller JL
    Blood; 2015 Jul; 126(5):665-72. PubMed ID: 25979948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activation of the gamma-globin gene in baboons treated with decitabine and in cultured erythroid progenitor cells involves different mechanisms.
    Chin J; Singh M; Banzon V; Vaitkus K; Ibanez V; Kouznetsova T; Mahmud N; DeSimone J; Lavelle D
    Exp Hematol; 2009 Oct; 37(10):1131-42. PubMed ID: 19576949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of ERF reactivates γ-globin expression in β-thalassemia.
    Bao X; Zhang X; Wang L; Wang Z; Huang J; Zhang Q; Ye Y; Liu Y; Chen D; Zuo Y; Liu Q; Xu P; Huang B; Fang J; Lao J; Feng X; Li Y; Kurita R; Nakamura Y; Yu W; Ju C; Huang C; Mohandas N; Li D; Zhao C; Xu X
    Am J Hum Genet; 2021 Apr; 108(4):709-721. PubMed ID: 33735615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoterpenes as therapeutic candidates to induce fetal hemoglobin synthesis and up-regulation of gamma-globin gene: An in vitro and in vivo investigation.
    Iftikhar F; Khan MBN; Musharraf SG
    Eur J Pharmacol; 2021 Jan; 891():173700. PubMed ID: 33137331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydroxyurea responses and fetal hemoglobin induction in beta-thalassemia/HbE patients' peripheral blood erythroid cell culture.
    Watanapokasin R; Sanmund D; Winichagoon P; Muta K; Fucharoen S
    Ann Hematol; 2006 Mar; 85(3):164-9. PubMed ID: 16389564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.
    Wilber A; Hargrove PW; Kim YS; Riberdy JM; Sankaran VG; Papanikolaou E; Georgomanoli M; Anagnou NP; Orkin SH; Nienhuis AW; Persons DA
    Blood; 2011 Mar; 117(10):2817-26. PubMed ID: 21156846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tenofovir disoproxil fumarate induces fetal hemoglobin production in K562 cells and β-YAC transgenic mice: A therapeutic approach for γ-globin induction.
    Khan F; Ali H; Musharraf SG
    Exp Cell Res; 2020 Sep; 394(2):112168. PubMed ID: 32653411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo.
    Pace BS; White GL; Dover GJ; Boosalis MS; Faller DV; Perrine SP
    Blood; 2002 Dec; 100(13):4640-8. PubMed ID: 12393583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BCL11A-targeted γ-globin gene induction by triterpenoid glycosides of Fagonia indica: A preclinical scientific validation of indigenous herb for the treatment of β-hemoglobinopathies.
    Iftikhar F; Khan MBN; Tehreem S; Kanwal N; Musharraf SG
    Bioorg Chem; 2023 Nov; 140():106768. PubMed ID: 37586133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
    Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
    Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.
    Perrine SP; Castaneda SA; Boosalis MS; White GL; Jones BM; Bohacek R
    Ann N Y Acad Sci; 2005; 1054():257-65. PubMed ID: 16339673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Erythroid Precursor Cells from β-Thalassemia Patients with
    Zuccato C; Cosenza LC; Zurlo M; Lampronti I; Borgatti M; Scapoli C; Gambari R; Finotti A
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.